Body

Janssen Compass®

Look to Janssen Compass® to help you understand your insurance coverage and cost support options, as well as guide you in navigating educational resources you want and need to feel confident on your Janssen therapy.

Throughout the program you can:

Connect... each time to the same Janssen Compass® Care Navigator who understands and offers education on your cancer and your Janssen medication

Learn... about resources to support you with cost, coverage, your personal wellness, and your emotional well-being throughout your treatment journey and beyond

Simplify... your experience through personalized education, every step of the way, to build confidence in what to expect and support in making decisions about your treatment with your doctor and loved ones

Your Janssen Compass® Care Navigator is a phone call away!

To schedule an introductory call with a Janssen Compass® Care Navigator:

Janssen Compass® is limited to education about your Janssen therapy, its administration, and/or your disease. It is intended to supplement your understanding of your therapy and is not intended to provide medical advice, replace a treatment plan from your doctor or nurse, or serve as a reason for you to start or stay on this medication.

Support Tools

  • Personalized appointment or refill reminders

Your Janssen CarePath Account

Sign up or log in to your personal Janssen CarePath Account at MyJanssenCarePath.com, so you can check your insurance coverage for RYBREVANT®; if eligible, enroll in the Janssen CarePath Savings Program; and sign up for treatment support.

Connecting with others in your community

Resources are available online that can offer support and help you connect with others who are living with your condition. These include local support groups, fundraising walks, outreach programs, online communities, and volunteer opportunities. The websites below can help you learn more about your condition and connect with others.

RYBREVANT® Website
RYBREVANT.com
This website contains additional information about treatment with RYBREVANT®. On this website, you can also get helpful information about your condition.

Lung cancer communities and organizations

EGFR Registers Website
egfrcancer.org
EGFR Registers is a grassroots patient-driven community dedicated exclusively to changing EGFR positive lung cancer into a manageable, chronic disease.

Exon 20 Group Website
exon20group.org
Exon 20 Group is dedicated to expediting exon 20-targeted drugs into—and through—clinical trials to benefit patients and the global oncology community.

The GO2 Foundation for Lung Cancer Website
go2foundation.org
The GO2 Foundation for Lung Cancer's mission is to change what it means to live with lung cancer and increase the survival rate of the world's number one cancer killer. It is a joint force between the Bonnie J. Addario Lung Cancer Foundation (ALCF) and the Lung Cancer Alliance (LCA).

Lung Cancer Foundation of America (LCFA) Website
lcfamerica.org
LCFA's mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.

LUNGevity Website
lungevity.org
LUNGevity is changing outcomes for people with lung cancer through research, education and support.

Back

IMPORTANT SAFETY INFORMATION
  • Minimize
  • Expand
  • Full Screen
  • Return to Website

What is RYBREVANT® (amivantamab-vmjw)?

RYBREVANT® is a prescription medicine used to treat adults:

  • in combination with carboplatin and pemetrexed as a first-line treatment for non-small cell lung cancer (NSCLC) that:
    • has spread to other parts of the body (metastatic) or cannot be removed by surgery, and
    • has a certain abnormal epidermal growth factor receptor “EGFR” gene(s)
  • alone for the treatment of non-small cell lung cancer (NSCLC) that:
    • has spread to other parts of the body (metastatic) or cannot be removed by surgery, and
    • has a certain abnormal EGFR gene(s), and whose disease has worsened on or after platinum-based chemotherapy.

Your healthcare provider will perform a test to make sure that RYBREVANT® is right for you. It is not known if RYBREVANT® is safe and effective in children.

IMPORTANT SAFETY INFORMATION

Before you receive RYBREVANT®, tell your healthcare provider about all of your medical conditions, including if you:

  • have a history of lung or breathing problems.
  • are pregnant or plan to become pregnant. RYBREVANT® can harm your unborn baby.

Females who are able to become pregnant:

  • Your healthcare provider should do a pregnancy test before you start treatment with RYBREVANT®.
  • You should use effective birth control (contraception) during treatment and for 3 months after your final dose of RYBREVANT®.
  • Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with RYBREVANT®.
  • are breastfeeding or plan to breastfeed. It is not known if RYBREVANT® passes into your breast milk. Do not breastfeed during treatment and for 3 months after your final dose of RYBREVANT®.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive RYBREVANT®?

  • RYBREVANT® will be given to you by your healthcare provider by intravenous infusion into your vein.
  • Your healthcare provider will decide the time between doses as well as how many treatments you will receive.
  • Your healthcare provider will give you medicines before each dose of RYBREVANT® to help reduce the risk of infusion-related reactions.
  • RYBREVANT® may be given in combination with the medicines carboplatin and pemetrexed. If you have any questions about these medicines, ask your healthcare provider.
  • If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment.

What should I avoid while receiving RYBREVANT®?

RYBREVANT® can cause skin reactions. You should limit your time in the sun during and for 2 months after your treatment with RYBREVANT®. Wear protective clothing and use sunscreen during treatment with RYBREVANT®.

What are the possible side effects of RYBREVANT®?

RYBREVANT® may cause serious side effects, including:

  • infusion-related reactions. Infusion-related reactions are common with RYBREVANT® and can be severe or serious. Tell your healthcare provider right away if you get any of the following symptoms during your infusion of RYBREVANT®:
  • shortness of breath
  • fever
  • chills
  • nausea
  • flushing
  • chest discomfort
  • lightheadedness
  • vomiting
  • lung problems. RYBREVANT® may cause lung problems that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your healthcare provider right away if you get any new or worsening lung symptoms, including shortness of breath, cough, or fever.
  • skin problems. RYBREVANT® may cause rash, itching, and dry skin. You may use alcohol-free moisturizing cream for dry skin. Tell your healthcare provider right away if you get any skin reactions. Your healthcare provider may treat you with a medicine(s) or send you to see a skin specialist (dermatologist) if you get skin reactions during treatment with RYBREVANT®. See “What should I avoid while receiving RYBREVANT®?”
  • eye problems. RYBREVANT® may cause eye problems. Tell your healthcare provider right away if you get symptoms of eye problems which may include:
  • eye pain
  • dry eyes
  • eye redness
  • blurred vision
  • changes in vision
  • itchy eyes
  • excessive tearing
  • sensitivity to light

Your healthcare provider may send you to see an eye specialist (ophthalmologist) if you get eye problems during treatment with RYBREVANT®. You should not use contact lenses until your eye symptoms are checked by a healthcare provider.

The most common side effects of RYBREVANT® in combination with carboplatin and pemetrexed include:

  • rash
  • infected skin around the nail
  • sores in the mouth
  • infusion-related reactions
  • feeling very tired
  • swelling of hands, ankles, feet, face, or all of your body
  • constipation
  • decreased appetite
  • nausea
  • COVID-19
  • diarrhea
  • vomiting
  • changes in certain blood tests

The most common side effects of RYBREVANT® when given alone:

  • rash
  • infusion-related reactions
  • infected skin around the nail
  • muscle and joint pain
  • shortness of breath
  • nausea
  • feeling very tired
  • swelling of hands, ankles, feet, face, or all of your body
  • sores in the mouth
  • cough
  • constipation
  • vomiting
  • changes in certain blood tests

Your healthcare provider may temporarily stop, decrease your dose, or completely stop your treatment with RYBREVANT® if you have serious side effects.

These are not all of the possible side effects of RYBREVANT®.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088.

General information about the safe and effective use of RYBREVANT®:

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your healthcare provider or pharmacist for information about RYBREVANT® that is written for health professionals.

Please read full Prescribing Information for RYBREVANT®.

cp-213277v4